Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Synthomer plc (LON:SYNT - Get Rating) insider Michael Willome bought 70,000 shares of Synthomer stock in a transaction dated Thursday, August 4th. The shares were purchased at an average cost of GBX 189 ($2.32) per share, for a total transaction of £132,300 ($162,112.49). Synthomer Price Performance

SYNT stock traded down GBX 5.01 ($0.06) during trading on Thursday, hitting GBX 187.59 ($2.30). The company had a trading volume of 4,723,418 shares, compared to its average volume of 1,152,781. Synthomer plc has a fifty-two week low of GBX 183.70 ($2.25) and a fifty-two week high of GBX 570.50 ($6.99). The company has a current ratio of 1.91, a quick ratio of 1.43 and a debt-to-equity ratio of 64.18. The firm has a market capitalization of £876.68 million and a price-to-earnings ratio of 391.04. The business has a 50 day moving average of GBX 252.48 and a 200 day moving average of GBX 289.86. Synthomer Cuts Dividend

The firm also recently announced a dividend, which will be paid on Friday, November 4th. Stockholders of record on Thursday, October 6th will be issued a GBX 4 ($0.05) dividend. The ex-dividend date is Thursday, October 6th. This represents a dividend yield of 1.7%. Synthomer's dividend payout ratio is 62.50%. Analysts Set New Price Targets

A number of research analysts have recently commented on SYNT shares. Berenberg Bank reduced their target price on shares of Synthomer from GBX 350 ($4.29) to GBX 275 ($3.37) and set a "hold" rating on the stock in a research report on Thursday. JPMorgan Chase & Co. dropped their price target on shares of Synthomer from GBX 430 ($5.27) to GBX 350 ($4.29) and set a "neutral" rating for the company in a research note on Wednesday. Finally, Barclays restated an "equal weight" rating and issued a GBX 323 ($3.96) price target on shares of Synthomer in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Synthomer currently has a consensus rating of "Hold" and a consensus price target of GBX 484.13 ($5.93).About Synthomer (Get Rating)

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.See AlsoChipotle Mexican Grill Or Shake Shak? Which Is The Tastier Play Activision Blizzard Banks On A Flurry Of New Content Energy Transfer Is A Value Among High-Yield Energy InfrastructureWarner Brothers Discovery is a Powerhouse Entertainment PlayThe Institutions Are Buying Under Armor Again

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Today, Kate’s guest is Rhys Williams, chief investment officer for the Opportunistic All Cap Equity, a long-short strategy at Spouting Rock Asset Management.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.